FdaApplication
NDA 021515
Identifiers
- fda_app_no: NDA021515
Properties
| Property | Value |
|---|---|
| applicant_name | BAUSCH HEALTH US LLC |
| application_type | NDA |
| approval_date | 2003-08-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE;ORAL |
| WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE;ORAL |
2 products